Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

New research, available as a preprint on the bioRxiv* server, has focused on the role played by T cell immunity, particularly CD8+ cytotoxic T cells, on preventing lethal infection with SARS-CoV-2 in mice infused with peptide-loaded antigen-presenting dendritic cells (DCs).

19 Aug 2021

Early clinical trial data in for whole virus COVID-19 vaccine candidate

In a study uploaded to the preprint server medRxiv*, the efficacy of a whole virion Coronavirus vaccine was determined by giving the vaccine to healthy adult volunteers, which generated a robust immune response with evidence of T-cell activation.

19 Aug 2021

White-tailed deer are highly susceptible to SARS-CoV-2 infection

The SARS-CoV-2 virus has been shown to infect a wide range of animals naturally and experimentally, and prior studies indicate deer are susceptible to infection. White-tailed deer (Odocoileus virginianus) fawns have been found to be susceptible to SARS-CoV-2.

19 Aug 2021

Vaccine nationalism may increase COVID-19 case numbers and the emergence of novel variants

The allocation of COVID-19 vaccine between countries has thus far tended toward vaccine nationalism, wherein countries stockpile vaccines to prioritize access for their citizenry over equitable vaccine sharing.

18 Aug 2021

Genomic surveillance is vital to combat COVID-19

Although the development and increasingly widespread availability of effective and safe vaccines provides the greatest hope for the future recovery from the increasingly devastating COVID-19 pandemic, genomic surveillance is emerging as a vital necessity to achieve effective mitigation and containment.

18 Aug 2021

Excess mortality from COVID-19 is the highest since 1918

A recent study provides an assessment of the ongoing pandemic by estimating excess deaths in Sweden, Switzerland, and Spain.

18 Aug 2021

Study shows how mesenchymal stromal cells regulate factors driving inflammation in COPD patients

A new phase I clinical study shows, for the first time, how treatment with a type of stem cell called mesenchymal stromal cells is able to regulate important factors driving inflammation in patients with chronic obstructive pulmonary disease (COPD) for a period for time.

18 Aug 2021

15-minute web tutorial can help women develop healthy bladder control habits

If your bladder leaks when you cough, sneeze or laugh, or every time you come home--even if you left 10 minutes ago--you’re not alone.

18 Aug 2021

The White House says boosters for all. Here’s what you need to know.

The Biden administration announced plans Wednesday to offer boosters to all U.S. adults as soon as next month, saying that recent data, including some made available only in the past few days, played a role in that decision.

18 Aug 2021

Study examines prevalence of neutralizing antibodies to HCoV-NL63 in healthy adults in Australia

A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.

18 Aug 2021

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

A CRISPR screening tool identified a new therapeutic target to treat acute myeloid leukemia (AML) that has the potential to leave patients with fewer side effects than current approaches, according to a new study from Penn Medicine published online in Molecular Cell.

18 Aug 2021

Rush to boosters sparks confusion, differing recommendations

When the Food and Drug Administration announced last week that a third dose of Moderna or Pfizer-BioNTech covid-19 vaccine may boost the immunity of some people who are immunocompromised, officials repeated their stance that fully vaccinated, healthy people do not need another dose.

18 Aug 2021

Federal vaccine program hasn’t helped those whose lives were altered by covid shot

Angela Marie Wulbrecht jumped at the first chance to get a covid-19 vaccine, driving three hours from her Santa Rosa, California, home to a mass-vaccination site on Jan. 19.

18 Aug 2021

Study suggests Harmony COVID-19 assay is superior to laboratory-based tests

A new study suggests a new coronavirus test developed by scientists from the University of Washington and the Brotman Baty Institute for Precision Medicine produces faster and more sensitive results than conventional PCR tests to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA.

18 Aug 2021

Study explores the role of nasal bacteria and provides clues to developing better flu, COVID-19 vaccines

While gut microbiota play a critical role in the induction of adaptive immune responses to influenza virus infection, the role of nasal bacteria in the induction of virus-specific adaptive immunity is less clear.

17 Aug 2021

HORIBA to showcase novel POCKIT Central PCR analyser at BEVA and Vets North

HORIBA UK Limited will be showcasing its new benchtop POCKIT™ Central* in-house veterinary PCR analyser on Stand C3 at the BEVA Congress.

From HORIBA Medical 17 Aug 2021

Have vaccines, will travel: On the road with a covid entrepreneur

While many businesses in this southwestern Montana "ghost town" reel in tourists with its mining and Wild West vigilante past, one businessman arrived offering a modern product: covid-19 vaccines.

17 Aug 2021

Researchers confirm the speed, simplicity and accuracy of new COVID-19 testing method

Researchers from the University of Birmingham, U.K., have confirmed the speed, accuracy, and simplicity of a novel, a highly sensitive testing method for COVID-19 that can be deployed at entertainment venues, airport arrival terminals, and in remote settings where clinical testing laboratories are not available.

17 Aug 2021

In Southeast Asia, robust immunity found up to 9 months after SARS-CoV-2 infection

Now, a new study posted to the bioRxiv* preprint server focuses on functional immune memory to SARS-CoV-2, up to nine months in a Southeast Asian cohort, in the absence of re-infection.

16 Aug 2021

Real-time genomics to track SARS-CoV-2 help contain transmission in New Zealand

A recent study discusses how New Zealand rapidly employed real-time genomics to contain new COVID-19 cases.

16 Aug 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

Early clinical trial data in for whole virus COVID-19 vaccine candidate

White-tailed deer are highly susceptible to SARS-CoV-2 infection

Vaccine nationalism may increase COVID-19 case numbers and the emergence of novel variants

Genomic surveillance is vital to combat COVID-19

Excess mortality from COVID-19 is the highest since 1918

Study shows how mesenchymal stromal cells regulate factors driving inflammation in COPD patients

15-minute web tutorial can help women develop healthy bladder control habits

The White House says boosters for all. Here’s what you need to know.

Study examines prevalence of neutralizing antibodies to HCoV-NL63 in healthy adults in Australia

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

Rush to boosters sparks confusion, differing recommendations

Federal vaccine program hasn’t helped those whose lives were altered by covid shot

Study suggests Harmony COVID-19 assay is superior to laboratory-based tests

Study explores the role of nasal bacteria and provides clues to developing better flu, COVID-19 vaccines

HORIBA to showcase novel POCKIT Central PCR analyser at BEVA and Vets North

Have vaccines, will travel: On the road with a covid entrepreneur

Researchers confirm the speed, simplicity and accuracy of new COVID-19 testing method

In Southeast Asia, robust immunity found up to 9 months after SARS-CoV-2 infection

Real-time genomics to track SARS-CoV-2 help contain transmission in New Zealand

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in